ORPH (ORPH:NASDAQ) rocketted at $7.44, representing a gain of 24.6%. The stock appeared on our News Catalysts scanner on Fri, Jun 18, 2021 at 01:51 PM in the 'BIOTECH' category. From Tue, Jun 08, 2021, the stock recorded 30.00% Up Days and 18.18% Green Days
The stock spiked on Thu, Jun 10, 2021 at $77.77 with a volume of 7M+.
About ORPH (ORPH:NASDAQ)
Orphazyme A/S is a Danish biotech company. It is engaged in the development of paradigm-changing medicines for the treatment of protein misfolding diseases.
Top 10 Gainers:
- MCAE (MCAE:NASDAQ), 100%
- Entera Bio Ltd. (ENTX:NASDAQ), 44.77%
- Bellerophon Therapeutics, Inc. (BLPH:NASDAQ), 30.39%
- ORPH (ORPH:NASDAQ), 24.62%
- Moxian, Inc. (MOXC:NASDAQ), 21.98%
- Loop Industries, Inc. (LOOP:NASDAQ), 20.55%
- KRBP (KRBP:NASDAQ), 20.54%
- AUUD (AUUD:NASDAQ), 18.54%
- Clearside Biomedical, Inc. (CLSD:NASDAQ), 18.5%
- SeaChange International, Inc. (SEAC:NASDAQ), 18.1%